StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)

Close on Nov 17, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Aytu BioPharma's EV/EBITDA was 2.8× on Jul 31, 2025, against 6.1× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20252.8×+1.4
2024Dec 31, 20241.4×–

More Aytu BioPharma figures

See a number that looks wrong?